4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0000899243-22-031083
Options or other derivatives
- Chief Executive Officer sold 850,000 shares at an average $0.58 ($490,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| First Light Acquisition Group, LLC Chief Executive Officer | 2022-09-12 | Sale · Class B Common Stock, par value $0.0001 per share | −450,000 | $1.00 | $450,000 | 2,874,677 | I |
| First Light Acquisition Group, LLC Chief Executive Officer | 2022-09-13 | Sale · Class B Common Stock, par value $0.0001 per share | −400,000 | $0.10 | $40,000 | 2,575,803 | I |
Loading xslF345X03/doc4.xml…